Table 6 |
|||||||
|
Safety of Immunomodulatory Polysaccharide Products Following Oral Intake |
|||||||
|
Category |
Source |
Test group |
Test |
Design |
Results |
Equivalent human dose* |
Reference |
|
|
|||||||
|
Arabino-galactans |
Argemone mexicana (arabinogalactan protein) |
Pregnant rats |
Develop-mental toxicity |
250, 500, or 1,00 mg/kg, gestational days 5-19 |
No developmental toxicity: NOAEL = 1 g/kg |
68 g |
[151] |
|
|
|||||||
|
♀ and ♂ rats |
Fertility |
250, 500, or 1,00 mg/kg, 1 month |
No effects on reproduction: NOAEL = 1 g/kg |
||||
|
|
|||||||
|
Fucoidans |
Undaria pinnatifida |
Rats |
Subchronic toxicity |
1.35 g/kg, 1 month |
No evidence of toxicity |
91.8 g |
[152] |
|
|
|||||||
|
Galacto-mannans |
Cyamopsis tetragonolobus |
Adolescent and adult ♂ rats |
Subchronic and chronic toxicity |
8% of diet, 6-67 weeks |
No evidence of toxicity |
8% of diet |
[153] |
|
|
|||||||
|
Rats |
Acute toxicity |
One 7.06 g/kg dose: observed 2 weeks |
LD50 = 7.06 g/kg |
480 g |
[96] |
||
|
|
|||||||
|
Subchronic and chronic toxicity |
1, 2, 4, 7.5 or 15% of diet, 3 months |
All doses ↓ ♀ BW; 7.5-15% ↓ ♂ BW; 15% ↓ bone marrow cellularity; ↓ kidney and liver weights |
1-15% of diet |
||||
|
|
|
||||||
|
19 adults with hypercholesterol-emia |
18 g/day, 1 year |
Short-term gastric bloating/loose stools, in 8 subjects, resolved in 7-10 days; 2 withdrew because of diarrhea. No toxicity for 13 subjects completing study |
18 g |
[154] |
|||
|
|
|
||||||
|
16 Type II diabetics |
26.4-39.6 g/day, 6 months |
No effects on hematologic, hepatic, or renal function |
39.9 g |
[155] |
|||
|
|
|
|
|||||
|
18 Type II diabetics |
30 g/day, 4 months |
30 g |
|||||
|
|
|||||||
|
Cyamopsis tetragonolobus (partially hydrolyzed guar gum) |
Mice & rats |
Acute toxicity |
One 6 g/kg dose; observed 2 weeks |
LD50 > 6 g/kg |
>408 g |
[156] |
|
|
|
|||||||
|
Rats |
Subchronic toxicity |
0.2, 1.0 or 5% of diet, 13 weeks |
No evidence of toxicity |
5% of diet |
|||
|
|
|||||||
|
0.5 or 2.5 g/kg, 1 month |
NOAEL > 2.5 g/kg |
>170 g |
[157] |
||||
|
|
|||||||
|
S. typhimurium |
Mutagenicity |
Ames test |
Not mutagenic |
NA |
|||
|
|
|||||||
|
Glucans |
Agaricus subrufescens (aqueous extract) |
Rats |
Subchronic toxicity |
0.63, 1.25, 2.5 or 5% of diet, 3 months |
NOAEL = 5% of diet |
5% of diet |
[158] |
|
|
|||||||
|
3 women with advanced cancers |
Case reports |
Specific identity of products, doses, and durations of intake unknown |
Severe hepatotoxicity; two patients died |
NA |
[97] |
||
|
|
|||||||
|
Agaricus subrufescens (freeze dried powder) |
24 normal adults and 24 adults with liver problems |
Subchronic toxicity |
3 g, 4 months |
No evidence of toxicity |
3 g |
[159] |
|
|
|
|||||||
|
Ganoderma lucidum (supplement) |
Elderly woman |
Case report |
1 year G. lucidum (and another unidentified product, initiated one month previous) |
Elevated liver enzymes and liver tissue damage |
NA |
[98] |
|
|
|
|||||||
|
Grifola frondosa (powder) |
Rats |
Acute toxicity |
One 2 g/kg dose |
No evidence of toxicity |
136 g |
[160] |
|
|
|
|||||||
|
Lentinula edodes (powder) |
10 adults |
Safety |
4 g/day for 10 weeks; repeated 3-6 months later |
50% of subjects experienced blood eosinophilia, ↑ eosinophil granule proteins in serum and stool, ↑GI symptoms |
4 g |
[99] |
|
|
|
|||||||
|
Lentinula edodes (SME) |
Nude mice |
Safety |
10% of diet days 1-18, 33-50 |
No adverse events |
10% of diet |
[80] |
|
|
|
|
||||||
|
61 men with prostate cancer |
0.1 g/kg, 6 months |
No adverse events |
6.8 g |
||||
|
|
|||||||
|
Lentinus lepideus (PG101) |
Female mice |
Subchronic toxicity |
0.5 g/kg, 24 days |
No evidence of toxicity |
34 g |
[92] |
|
|
|
|||||||
|
Phellinus linteus (crude extract) |
Rats |
Acute toxicity |
One 5 g/kg dose; observed 2 weeks |
LD50 > 5 g/kg |
349 g |
[161] |
|
|
|
|||||||
|
Pleurotus ostreatus (aqueous extract) |
Mice |
Acute toxicity |
One 3 g/kg dose; observed 1 day |
LD50 > 3 g/kg |
>204.g |
[100] |
|
|
|
|||||||
|
Subacute toxicity |
319 mg/kg, 1 month |
Hemorrhages in intestine, liver, lung, kidney; inflammation and microabscesses in liver |
21.7 g |
||||
|
|
|||||||
|
Saccharomyces cerevisiae (particulate glucan [WGP]) |
Rats |
Acute toxicity |
One 2 g/kg, observed 2 weeks |
LD50 > 2 g/kg |
>136 g |
[144] |
|
|
|
|||||||
|
Subchronic toxicity |
2, 33.3 or 100 mg/kg, 3 months |
NOAEL = 100 mg/kg |
6.80 g |
||||
|
|
|||||||
|
Heteroglycans |
Trametes versicolor (PSP) |
Rats |
Subchronic toxicity |
1.5, 3.0 or 6.0 mg/kg, 2 months |
No evidence of toxicity |
408 mg |
[162] |
|
|
|||||||
|
Rats & monkeys |
Subchronic and chronic toxicity |
100-200X equivalent human dose, 6 months |
No evidence of toxicity |
NA |
|||
|
|
|||||||
|
Trametes versicolor (PSK) |
Humans with colon cancer |
Safety |
3 g/day, up to 7 years |
No significant adverse events |
3 g |
[57] |
|
|
|
|
|
|||||
|
Humans with colorectal cancer |
3 g/day, 2 years |
3 g |
[58] |
||||
|
|
|||||||
|
Mannans |
Aloe vera gel |
Dogs |
Acute toxicity |
Fed one 32 g/kg; observed 2 weeks |
LD50 > 32 g/kg |
>2,176 g |
Bill Pine, personal communi-cation |
|
|
|
||||||
|
Rats |
One 21.5 g/kg; observed 2 weeks |
LD50 > 10 g/kg |
>680 g |
||||
|
|
|||||||
|
*150 lb adult |
|||||||
|
Ramberg et al. Nutrition Journal 2010 9:54 doi:10.1186/1475-2891-9-54 |
|||||||